The Role of Toll-Like Receptors (TLR-2 and -4) and Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) in Human Term and Preterm Labor

Reproductive Sciences

Volumn 16, Issue 9, 2009, Pages 843-856

  Youssef, Refaat E ^a   Ledingham, Marie Anne ^b   Bollapragada, Shrikant S ^c   O'gorman, Neil ^c   Jordan, Fiona ^c   Young, Anne ^c   Norman, Jane E ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b QUEEN MOTHER S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Inflammation; mechanism of human parturition

Indexed keywords

CONTRACEPTIVE AGENT; LIPOPOLYSACCHARIDE; MEDROXYPROGESTERONE ACETATE; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; BIOPSY; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MYOMETRIUM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREMATURE LABOR; TISSUE CULTURE TECHNIQUE;

ADULT; BIOPSY; CONTRACEPTIVE AGENTS, FEMALE; DRUG INTERACTIONS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MEDROXYPROGESTERONE 17-ACETATE; MYELOID CELLS; MYOMETRIUM; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TISSUE CULTURE TECHNIQUES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 70350732614     PISSN: 19337191     EISSN: None     Source Type: Journal    
DOI: 10.1177/1933719109336621     Document Type: Article

References (56)

1. Dod J.M., Flenady V.J., Cincotta R., Crowther C.A. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol. 2008; 112 (1): 127 - 134.
2. Kelly R.W. Inflammatory mediators and parturition. Rev Reprod. 1996; 1 (2): 89 - 96.
3. Thomson A.J., Telfer J.F., Young A., et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod. 1999; 14 (1): 229 - 236.
4. Young A., Thomson A., Ledingham M., Jordan F., Greer I., Norman J.E. Immunolocalization of pro-inflammatory cytokines in myometrium, cervix and fetal membranes during human parturition at term. Biol Reprod. 2002; 66 (2): 445 - 449.
5. Osman I., Young A., Ledingham M.A., et al. Leukocytes density and pro-inflammatory cytokines expression in human fetal membranes, deciduas, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003; 9 (1): 41 - 45.
6. Keski-Nisula L., Aalto M.L., Katila M.L., Kirkinen P. Intrauterine Inflammatio at term: a histopathologic study. Hum Pathol. 2000; 31 (7): 841 - 846.
7. Kelly R.W. Inflammatory mediators and cervical ripening. J Reprod Immunol. 2002; 57 (1-2): 217 - 224.
8. Ledingham M., Thomson A., Macara L., Young A., Greer I., Norman J.E. Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod. 2000; 6 (11): 1041 - 1048.
9. Allport V.C., Pieber D., Slater D.M., Newton R., White J.O., Bennett P.R. Human labour is associated with nuclear factor-kappa B activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal. ’ Mol Hum Reprod. 2001; 7 (6): 581 - 586.
10. Romero R., Mazor M., Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol. 1991; 165 (4 pt 1): 969 - 971.
11. Hargreaves D.C., Medzhitov R. Innate sensors of microbial infection. J Clin Immunol. 2005; 25 (6): 503 - 510.
12. Armant M.A., Fenton M.J. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biology. 2002; 3 (8): reviews 3011: 1 - 6.
13. Pasare C., Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Micobes Infect. 2004; 6 (15): 1382 - 1387.
14. Kim Y.M., Romero R., Chaiworapongsa T., et al. Toll-like receptor 2 and 4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol. 2004 ; 191 (4): 1346 - 1355.
15. O’Brien M., Morrison J.J., Smith T.J. Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB and RGS12 gene expression in human myometrium at labor. Reprod Sci. 2008; 15 (4): 382 - 393.
16. Wang H., Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of Toll-like receptor 4. Biol Reprod. 2003; 69 (6): 1957 - 1963.
17. Lorenz E., Hallman M., Martilla R., Haataja R., Schwartz D.A. Association between the Asp 299 Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res. 2002; 52 (3): 373 - 376.
18. Tsan M., Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol. 2004; 76 (3): 514 - 519.
19. Sato M., Sano H., Iwaki D., et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collection surfactant protein A. J Immunol. 2003; 171 (1): 417 - 425.
20. Condon J.C., Jeyasuria P., Faust J.M., Medelson C. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci U S A. 2004; 101 (14): 4978 - 4983.
21. Leong A.S.-Y., Norman J.E., Smith R. Vascular and myometrial changes in the human uterus at term. Reprod Sci. 2008; 15 (1): 59 - 65.
22. Kim C.J., Kim J.S., Kim Y.M., et al. Fetal macrophages are not present in the myometrium of women with labor at term. Am J Obstet Gynecol. 2006 ; 195 (3): 829 - 833.
23. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor on neutrophils and monocytes. J Immunol. 2000 ; 164 (10): 4991 - 4995.
24. Klesney-Tait J., Turnbull I.R., Colonna M. The TREM receptor family and signal integration. Nat Immunol. 2006 ; 7 (12): 1266 - 1273.
25. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Kim S., Dinarello C.A. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol. 2006; 80 (6): 1454 - 1461.
26. Fortin C.F., Lesur O., Fulop T. Effects of TREM-1 activation in human neutrophils: activation of signalling pathways, recruitment into lipid rafts and association with TLR4. Int Immunol. 2007; 19 (1): 41 - 50.
27. Ornatowska M., Azim A.C., Wang X., et al. Functional genomics of silencing TREM-1 on TLR4 signalling in macrophages. Am J Physiol Lung Cell Mol Phyiol. 2007; 293 (6): 1377 - 1384.
28. Ledingham M.A., Thomson A.J., Jordan F., Young A., Crawford M., Norman J.E. Cell adhesion molecule expression in the cervix and myometrium during pregnancy and parturition. Obstet Gynecol. 2001; 97 (2): 235 - 242.
29. Romero R., Espinoza J., Kusanovic J.P., et al. The preterm parturition syndrome. BJOG. 2006; 113 (suppl 3): 17 - 42.
30. Robin P., Boulven I., Desmyter C., Harbon S., Leiber D. ET-1 stimulates ERK signaling pathway through sequential activation of PKC and Src in rat myometrial cells. Am J Physiol Cell Phyiol. 2002; 283 (1): 251 - 260.
31. Zhong M., Yang M., Sanborn B.M. Extracellular signal-regulated kinase ½ activation by myometrial oxytocin receptor involves Galpha (q) Gbetagamma and epidermal growth factor receptor tyrosine kinase activation. Endocrinology. 2003; 144 (7): 2947 - 2956.
32. Ohmichi M., Koike K., Kimura A., et al. Role of mitogenactivated protein kinase pathway in prostaglandin F2 alpha-induced rat puerperal uterine contraction. Endocrinology. 1997; 138 (8): 3103 - 3111.
33. Pahl H.L. Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene. 1999; 18 (49): 6853 - 6866.
34. Chapman N.R., Europe-Finner G.N., Robson S.C. Expression and deoxyribonucleic acid-binding activity of the nuclear factor kappa B family in the human myometrium during pregnancy and labour. J Clin Endocrinol Metab. 2004; 89 (11): 5683 - 5693.
35. Elliott C.L., Allport V.C., Loudon J.A., Wu G.D., Bennett P.R. Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod. 2001; 7 (8): 787 - 790.
36. Ilievski V., Lu S.J., Hirsch E. Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci. 2007; 14 (4): 315 - 320.
37. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002; 20: 197 - 216.
38. Yamamoto M., Sato S., Hemmi H. Role of adaptor TRIF in he MyD88-independent toll-like receptor signalling pathway. Science. 2003; 301 (5633): 640 - 643.
39. Takeda K., Akira S. TLR signalling pathways. Semin Immunol. 2004 ; 16 (1): 3 - 9.
40. Hsu L., Park J.M., Zhang K., et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature. 2004; 428 (6980): 341 - 345.
41. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001; 410 (6832): 1103 - 1107.
42. Nathan C., Ding A. TERM-1: a new regulator of innate immunity in sepsis syndrome. Nat Med. 2001; 7 (5): 530 - 532.
43. Bleharski J.R., Kiessler V., Buonsanti C., et al. A role for triggering receptor expressed on myeloid cells-1 in host defence during he early-induced and adaptive phases of the immune response. J Immunol. 2003; 170 (7): 3812 - 3818.
44. Knapp S., Gibot S., de Vose A., Versteeg H.H., Colonna M., van der Poll T. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Imunol. 2004; 173 (12): 7131 - 7134.
45. Gibot S., Kolopp-Sarda M.N., Béné M.C., et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004; 200 (11): 1419 - 1426.
46. Cohen J. TREM-1 in sepsis. Lancet. 2001; 358 (9284): 776 - 778.
47. Colonna M., Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003 ; 187 (suppl 2): 397 - 401.
48. Gibot S., Cravoisy A. Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res. 2004; 2 (3): 181 - 187.
49. Gibot S. The therapeutic potential of TREM-1 modulation in the treatment of sepsis and beyond. Curr Opin Investig Drugs. 2006 ; 7 (5): 438 - 442.
50. Gingras M.C., Lapillonne H., Marglin J.F. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002; 38 (11): 817 - 824.
51. Liu-Bryan R., Terkeltaub R. Evil humors take their toll as innate immunity makes gouty joints TREM-ble. Arthritis Rheum. 2006; 54 (2): 383 - 386.
52. Koussoulas V., Vassiliou S., Demonakou M., et al. Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease. Eur J Gastroenterol Hepatol. 2006; 18 (4): 375 - 379.
53. Gibot S., Cravoisy A., Levy B., Bene M.C., Faure G., Bollaert P.E. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004; 350 (5): 451 - 458.
54. Csapo A. Progesterone block. Am J Anat. 1956 ; 98 (2): 273 - 291.
55. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003; 348 (24): 2379 - 2385.
56. American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Use of Progesterone to reduce preterm birth. Obstet Gynecol. 2003; 102 (5 pt 1): 1115 - 1116.